Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable peptidoglycan binding activity; peptidoglycan immune receptor activity; and protein heterodimerization activity. Acts upstream of or within biological process involved in interaction with host; negative regulation of natural killer cell differentiation involved in immune response; and negative regulation of type II interferon production. Predicted to be located in extracellular region. Predicted to be part of protein-containing complex. Is expressed in several structures, including alimentary system; genitourinary system; immune system; liver; and musculature. Orthologous to human PGLYRP4 (peptidoglycan recognition protein 4).